Bronchoscopic Re-biopsy for Mutational Analysis of Non-small Cell Lung Cancer

Lung

Volumn 194, Issue 3, 2016, Pages 371-378

  Kirita, Keisuke ^a,b   Izumo, Takehiro ^a   Matsumoto, Yuji ^a   Hiraishi, Yoshihisa ^a   Tsuchida, Takaaki ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Bronchoscopy; Driver oncogene mutation; EBUS; Lung cancer; Re biopsy

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GENOMIC DNA; HYBRID PROTEIN; ONCOPROTEIN; PLATINUM COMPLEX; ROS1 PROTEIN; UNCLASSIFIED DRUG; PROTEIN TYROSINE KINASE; ROS1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RESISTANCE; CARCINOGENESIS; DISEASE COURSE; DRUG RESPONSE; ENDOBRONCHIAL ULTRASONOGRAPHY; ENDOBRONCHIAL ULTRASOUND GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; FEMALE; FINE BIOPSY NEEDLE; FUSION GENE; GENE MUTATION; HUMAN; LUNG ADENOCARCINOMA; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULARLY TARGETED THERAPY; MUTATIONAL ANALYSIS; NON SMALL CELL LUNG CANCER; POINT MUTATION; PRIORITY JOURNAL; REAL TIME ULTRASOUND SCANNER; REPEAT PROCEDURE; RETROSPECTIVE STUDY; SMALL CELL LUNG CANCER; TRANSBRONCHIAL BIOPSY; TUMOR BIOPSY; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE; GENETICS; LUNG TUMOR; LYMPH NODE; MEDIASTINUM; PATHOLOGY; PROTO ONCOGENE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, NEOPLASM; ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION; FEMALE; GENES, ERBB-1; HUMANS; LUNG NEOPLASMS; LYMPH NODES; MALE; MEDIASTINUM; MIDDLE AGED; MOLECULAR TARGETED THERAPY; ONCOGENE PROTEINS, FUSION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RETROSPECTIVE STUDIES;

EID: 84960091284     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-016-9864-5     Document Type: Article

References (31)

1. Ferlay JSI, Ervik M. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. http://globocan.iarc.fr, accessed on Dec 3 2014
2. Smyth CM, Stead RJ (2002) Survey of flexible fibreoptic bronchoscopy in the United Kingdom. Eur Respir J 19(3):458–463
3. Kikuchi E, Yamazaki K, Sukoh N et al (2004) Endobronchial ultrasonography with guide-sheath for peripheral pulmonary lesions. Eur Respir J 24(4):533–537
4. Izumo T, Sasada S, Chavez C et al (2015) The diagnostic value of histology and cytology samples during endobronchial ultrasound with a guide sheath. Jpn J Clin Oncol 45(4):362–366
5. Izumo T, Sasada S, Chavez C et al (2015) Radial endobronchial ultrasound images for ground-glass opacity pulmonary lesions. Eur Respir J 45(6):1661–1668
6. Herth FJ, Rabe KF, Gasparini S et al (2006) Transbronchial and transoesophageal (ultrasound-guided) needle aspirations for the analysis of mediastinal lesions. Eur Respir J 28(6):1264–1275
7. Lynch TJ, Bell DW, Sordella R et al (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350(21):2129–2139
8. Tsao AS, Tang XM, Sabloff B et al (2006) Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer. J Thorac Oncol 1(3):231–239
9. Fukuoka M, Wu YL, Thongprasert S et al (2011) Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS). J Clin Oncol 29(21):2866–2874
10. Rosell R, Carcereny E, Gervais R et al (2012) Spanish Lung Cancer Group in collaboration with Groupe Francais de P-C, Associazione Italiana Oncologia T. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol 13(3):239–246
11. Yang JC-H, Wu Y-L, Schuler M et al (2015) Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials. Lancet Oncol 16(2):141–151
12. Janne PA, Yang JC, Kim DW et al (2015) AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer. N Engl J Med 372(18):1689–1699
13. Sequist LV, Soria JC, Goldman JW et al (2015) Rociletinib in EGFR-mutated non-small-cell lung cancer. N Engl J Med 372(18):1700–1709
14. Yu HA, Arcila ME, Rekhtman N et al (2013) Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers. Clin Cancer Res 19(8):2240–2247
15. Lara PN Jr, Chansky K, Shibata T et al (2010) Common arm comparative outcomes analysis of phase 3 trials of cisplatin + irinotecan versus cisplatin + etoposide in extensive stage small cell lung cancer: final patient-level results from Japan Clinical Oncology Group 9511 and Southwest Oncology Group 0124. Cancer 116(24):5710–5715
16. Soda M, Choi YL, Enomoto M et al (2007) Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448(7153):561–566
17. Chan BA, Hughes BG (2015) Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. Transl Lung Cancer Res 4(1):36–54
18. Shaw AT, Kim DW, Nakagawa K et al (2013) Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 368(25):2385–2394
19. Gadgeel SM, Gandhi L, Riely GJ et al (2014) Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study. Lancet Oncol 15(10):1119–1128
20. Shaw AT, Kim DW, Mehra R et al (2014) Ceritinib in ALK-rearranged non-small-cell lung cancer. N Engl J Med 370(13):1189–1197
21. Scagliotti GV, Parikh P, von Pawel J et al (2008) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26(21):3543–3551
22. Johnson DH, Fehrenbacher L, Novotny WF et al (2004) Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 22(11):2184–2191
23. Hellmann MD, Chaft JE, William WN et al (2014) Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. Lancet Oncol 15(1):e42–50
24. Bosc C, Ferretti GR, Cadranel J et al (2015) Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLC. Target Oncol 10(2):247–253
25. Arcila ME, Oxnard GR, Nafa K et al (2011) Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay. Clin Cancer Res 17(5):1169–1180
26. Hata A, Katakami N, Yoshioka H et al (2013) Rebiopsy of non-small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor: comparison between T790M mutation-positive and mutation-negative populations. Cancer 119(24):4325–4332
27. Asano F, Aoe M, Ohsaki Y et al (2012) Deaths and complications associated with respiratory endoscopy: a survey by the Japan Society for Respiratory Endoscopy in 2010. Respirology 17(3):478–485
28. Hayama M, Izumo T, Matsumoto Y et al (2015) Complications with endobronchial ultrasound with a guide sheath for the diagnosis of peripheral pulmonary lesions. Respir Int Rev Thorac Dis 90:129–135
29. Yoon HJ, Lee HY, Lee KS et al (2012) Repeat biopsy for mutational analysis of non-small cell lung cancers resistant to previous chemotherapy: adequacy and complications. Radiology 265(3):939–948
30. Wang Memoli JS, Nietert PJ et al (2012) Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. Chest 142(2):385–393
31. Takai M, Izumo T, Chavez C et al (2014) Transbronchial needle aspiration through a guide sheath with endobronchial ultrasonography (GS-TBNA) for peripheral pulmonary lesions. Ann Thorac Cardiovasc Surg 20(1):19–25